Evidence map›Paper›PMID 10485881›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1999

Evidence for the function of an exonic splicing enhancer after the first catalytic step of pre-mRNA splicing.

S L Chew, H X Liu, A Mayeda, A R Krainer

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. The SR protein family.Genome biology · 2009
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Ischemia induces a translocation of the splicing factor tra2-beta 1 and changes alternative splicing patterns in the brain.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2002
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

S L ChewCold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.
H X Liu
A Mayeda
A R Krainer

Funding

BIOCHEMISTRY OF PREMRNA SPLICINGR01GM042699 · NIGMS · COLD SPRING HARBOR LABORATORY · PI Adrian R Krainer · 1989 to 2026
$8.8M
Biochemistry of Pre-mRNA SplicingR37GM042699 · NIGMS · COLD SPRING HARBOR LABORATORY · PI KRAINER, ADRIAN R · 2012 to 2021
$7.7M
NIGMS NIH HHS GM42699NIGMS NIH HHS R01 GM042699NIGMS NIH HHS R37 GM042699Wellcome Trust
6 · The paper itself

Abstract

Exonic splicing enhancers (ESEs) activate pre-mRNA splicing by promoting the use of the flanking splice sites. They are recognized by members of the serine/arginine-rich (SR) family of proteins, such as splicing factor 2/alternative splicing factor (SF2/ASF), which recruit basal splicing factors to form the initial complexes during spliceosome assembly. The in vitro splicing kinetics of an ESE-dependent IgM pre-mRNA suggested that an SF2/ASF-specific ESE has additional functions later in the splicing reaction, after the completion of the first catalytic step. A bimolecular exon ligation assay, which physically uncouples the first and second catalytic steps of splicing in a trans-splicing reaction, was adapted to test the function of the ESE after the first step. A 3' exon containing the SF2/ASF-specific ESE underwent bimolecular exon ligation, whereas 3' exons without the ESE or with control sequences did not. The ESE-dependent trans-splicing reaction occurred after inactivation of U1 or U2 small nuclear ribonucleoprotein particles, compatible with a functional assay for events after the first step of splicing. The ESE-dependent step appears to take place before the ATP-independent part of the second catalytic step. Bimolecular exon ligation also occurred in an S100 cytosolic extract, requiring both the SF2/ASF-dependent ESE and complementation with SF2/ASF. These data suggest that some ESEs can act late in the splicing reaction, together with appropriate SR proteins, to enhance the second catalytic step of splicing.

Indexed as

CatalysisAdenosine TriphosphateAdenoviridaeEnhancer Elements, GeneticEscherichia coliExonsImmunoglobulin MKineticsModels, GeneticNuclear ProteinsOligonucleotidesRNA-Binding ProteinsRNA PrecursorsRNA SplicingSerine-Arginine Splicing FactorsTime FactorsAdenosine TriphosphateImmunoglobulin MNuclear ProteinsOligonucleotidesRNA-Binding ProteinsRNA PrecursorsSerine-Arginine Splicing Factors

Identifiers

PMID10485881
PMCPMC17938

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.